Web Analytics Made Easy - StatCounter

Tender for Pocurement Of Drugs (innovator/original Molecules) - Name Of Items :, Abemaciclib, Abemaciclib, Alectinib, Alpelisib, Alteplase, Amivantamab, Asciminib, Atezolizumab, Avelumab, Brentuximab Vedotin, Capecitabine+cyclophosphamide, Capecitabine+cyclophosphamide, Capmatinib, Carmustine, Cladribine, Dabrafenib, Dabrafenib, Dacomitinib, Dacomitinib, Daratumumab + Hyaluronidase-fihj, Darolutamide, Docetaxel Nanosomal(lipid Suspension), Docetaxel Nanosomal(lipid Suspension), Docetaxel Nanosomal(lipid Suspension), Durvalumab, Durvalumab, Enfortumab Vedotin, Enfortumab Vedotin, Entrectinib, Entrectinib, Enzalutamide, Factor Vii Eptacog Alfa(human Recombinant Coagulation Factor Vii Activated R-dna Origin), Factor Vii Eptacog Alfa(human Recombinant Coagulation Factor Vii Activated R-dna Origin), Fosfestrol, Fosnetupitant+palonosetron, Gilteritinib, Glofitamab, Glofitamab, Goserelin, Goserelin, Idarubicin, Imatinib, Imatinib, Inotuzumab, Ipilimumab, Irinotecan Liposomal, Isavuconazole, Isavuconazole, Leuprolide Acetate, Lorlatinib, Lorlatinib, Luspatercept, Luspatercept, Mercaptopurine, Meropenem, Meropenem, Mycobacterium W.(heat Killed) Immunomodulator, Nanosomal Paclitaxel Lipid Suspension, Nanosomal Paclitaxel Lipid Suspension, Nimotuzumab, Nintedanib, Nintedanib, Obinutuzumab, Osimertinib, Osimertinib, Paclitaxel Nanoparticle, Palanosetron+netupitant(combipack), Panitumumab, Pegaspargase, Pembrolizumab, Pertuzumab+trastuzumab, Pertuzumab+trastuzumab, Polatuzumab Vedotin, Ramucirumab, Ramucirumab, Ribociclib, Ruxolitinib, Ruxolitinib, Ruxolitinib, Ruxolitinib, Sodium Copper Chlorophyllin, Sodium Copper Chlorophyllin, Teclistamab, Teclistamab, Tepotinib, Thyrotropin Alfa, Tocilizumab, Tocilizumab, Tocilizumab, Toripalimab, Trametinib, Trametinib, Trastuzumab Deruxtecan, Tremelimumab, Triptorelin, Triptorelin, Triptorelin, Venetoclax, Venetoclax, Venetoclax, Voriconazole, Voriconazole, Voriconazole in Mumbai - Maharashtra

Tender Details
Reference # :
40693579
Description :
Tenders for Pocurement Of Drugs (innovator/original Molecules) - Name Of Items :, Abemaciclib, Abemaciclib, Alectinib, Alpelisib, Alteplase, Amivantamab, Asciminib, Atezolizumab, Avelumab, Brentuximab Vedotin, Capecitabine+cyclophosphamide, Capecitabine+cyclophosphamide, Capmatinib, Carmustine, Cladribine, Dabrafenib, Dabrafenib, Dacomitinib, Dacomitinib, Daratumumab + Hyaluronidase-fihj, Darolutamide, Docetaxel Nanosomal(lipid Suspension), Docetaxel Nanosomal(lipid Suspension), Docetaxel Nanosomal(lipid Suspension), Durvalumab, Durvalumab, Enfortumab Vedotin, Enfortumab Vedotin, Entrectinib, Entrectinib, Enzalutamide, Factor Vii Eptacog Alfa(human Recombinant Coagulation Factor Vii Activated R-dna Origin), Factor Vii Eptacog Alfa(human Recombinant Coagulation Factor Vii Activated R-dna Origin), Fosfestrol, Fosnetupitant+palonosetron, Gilteritinib, Glofitamab, Glofitamab, Goserelin, Goserelin, Idarubicin, Imatinib, Imatinib, Inotuzumab, Ipilimumab, Irinotecan Liposomal, Isavuconazole, Isavuconazole, Leuprolide Acetate, Lorlatinib, Lorlatinib, Luspatercept, Luspatercept, Mercaptopurine, Meropenem, Meropenem, Mycobacterium W.(heat Killed) Immunomodulator, Nanosomal Paclitaxel Lipid Suspension, Nanosomal Paclitaxel Lipid Suspension, Nimotuzumab, Nintedanib, Nintedanib, Obinutuzumab, Osimertinib, Osimertinib, Paclitaxel Nanoparticle, Palanosetron+netupitant(combipack), Panitumumab, Pegaspargase, Pembrolizumab, Pertuzumab+trastuzumab, Pertuzumab+trastuzumab, Polatuzumab Vedotin, Ramucirumab, Ramucirumab, Ribociclib, Ruxolitinib, Ruxolitinib, Ruxolitinib, Ruxolitinib, Sodium Copper Chlorophyllin, Sodium Copper Chlorophyllin, Teclistamab, Teclistamab, Tepotinib, Thyrotropin Alfa, Tocilizumab, Tocilizumab, Tocilizumab, Toripalimab, Trametinib, Trametinib, Trastuzumab Deruxtecan, Tremelimumab, Triptorelin, Triptorelin, Triptorelin, Venetoclax, Venetoclax, Venetoclax, Voriconazole, Voriconazole, Voriconazole
Ownership :
Sector :
Tender Values
Value :
3,200,000,000
EMD :
500,000
Doc. Cost :
NA
Important Dates
Due date :
15 Jul, 2025
Open date :
16 Jul, 2025
Publish date :
11 Jun, 2025
Location
Location :
Mumbai - Maharashtra ( IN )
Connect us via What's Up